PubMed laboratory research record [PMID: 39990872] PubMed record related to this compound for laboratory literature review
However, those who maintained structured eating patterns and physical activity during and after treatment had better long-term outcomes than medication-only approaches
Considerations for specific populations: Individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should avoid these medications Pregnant or nursing women are advised not to use semaglutide or Zepbound Those with a history of pancreatitis, certain thyroid cancers, or a slow digestive system should exercise caution While Zepbound may potentially present more frequent or severe side effects due to its higher potency, the overall risk profile is similar to that of semaglutide
A physico-chemical study on amphiphilic cyclodextrin/liposomes nanoassemblies with drug carrier potential
Impact of calorie restriction on energy metabolism in humans
Available at: Vicari, E., La Vignera, S., & Calogero, A
